TCTMD (10/25, O’Riordan) reports, “Older adults prescribed a stimulant are at a higher risk for adverse cardiovascular events early, but that risk drops off with long-term use,” investigators concluded in a “propensity-matched analysis” that “included 6,457 older adults exposed to stimulants with 24,853 adults who were not prescribed a stimulant during the study period.” The findings were published online Oct. 25 in JAMA Network Open.
Psychiatric News (10/25) reports, “Older adults prescribed stimulant medications appear to be at an elevated risk of cardiovascular problems in the first 30 days after beginning the treatment,” investigators concluded in a study that “used hospital and prescription databases to assess the cardiovascular outcomes of 6,457 Ontario residents aged 66 years and older who received a new prescription for a stimulant (for example, amphetamine, methylphenidate, lisdexamfetamine, or dextroamphetamine) between January 1, 2002, and March 31, 2015.” Next, “these adults were matched with a control group of 24,853 similarly aged adults who did not take any stimulants during this time.”
Related Links:
— “Stimulants Linked to Early Risk of CV Events in Elderly “Michael O’Riordan, TCTMD, October 25, 2021